New FDA Fecal Transplant Guidance Should Ease Ferring’s Path To Commercialization

 
• By Sarah Karlin-Smith
open path with sunrise
FDA finalized a draft guidance on unapporved fecal transplants for C. diff infections ahead of likely first product approval. • Source: Shutterstock

More from Compliance

More from Pink Sheet